Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Negative gross margin

<< Previous

Bullboard Posts

Next >>

Comment by allibabbaon Nov 15, 2021 12:08pm

86 Views

Post# 34127570

RE:RE:RE:RE:RE:Negative gross margin

Don't get me wrong, I don't think that this company is going to fold anytime soon, however it will be many years down the road before you see cannabis drug to replace antibiotics or any other drug for that matter. This process is very long and gruelling and big pharma is trying to block it from happening. If there is still money left by the time cannabis drugs become mainstream they might have a chance. For now it's an R&D company doing small volume channel sales. Just my opinion of course. GLTA

<< Previous

Bullboard Posts

Next >>

AtkinsRéalis supports Poland’s nuclear power endeavour